The Agency’s shift on HRT was based on a comprehensive review of data that assessed its benefits and risks since the publication of the Women’s Health Initiative trials.
Hormone therapy drugs have carried box warning labels for years. Food and Drug Administration Commissioner Marty Makary talks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback